Connect with us

Technology

ShiraTronics Unveils Data on their Neurostimulation System for Chronic Migraine

Published

on

MIAMI BEACH, Fla., July 16, 2024 /PRNewswire/ — ShiraTronics, a trailblazing clinical-stage neurostimulation company, proudly presented findings from its Australian Pilot Study, RELIEV-CM, at the American Society of Pain and Neuroscience (ASPN) Pain Conference. This pioneering study showcases the world’s first fully implantable neurostimulation system specifically engineered for chronic migraine.

Study participants have shown significant improvements in pain levels, migraine-days, and quality of life indicators

Promising Potential Migraine Treatment

The ASPN (American Society of Pain & Neuroscience) Conference, a premier gathering of the world’s leading experts in pain management and neuromodulation, was the perfect venue for ShiraTronics to present their Pilot Study results. The presentation highlighted ShiraTronics’ leadership in medical innovation and reinforced its commitment to addressing unmet patient needs in the realm of chronic migraine.

Dr. Steven Falowski, a renowned neurosurgeon from The Argires Marotti Neurological Associates Clinic in Lancaster, PA, and a leading expert in neurostimulation therapies, presented the compelling 12-week results. He emphasized the potential transformative impact of ShiraTronics’ system, which may offer a promising treatment for chronic migraine sufferers. ShiraTronics’ system is a minimally invasive, head-located device designed to provide continuous stimulation without interruption.

About the RELIEV-CM Pilot Study

The RELIEV-CM Pilot Study is evaluating the preliminary safety and performance of the ShiraTronics Migraine Therapy System. The system is designed to provide a discreet, continuous solution for chronic migraine sufferers. Chronic migraine, affecting millions worldwide, is characterized by severe headaches occurring at least 15 days per month, frequently accompanied by debilitating symptoms such as nausea and light sensitivity. Current treatment options often fail to deliver consistent and lasting relief.

ShiraTronics’ innovative system administers precise electrical pulses intended to disrupt migraine pain signals. Its unique, head-located design marks a significant departure from traditional neurostimulation systems typically intended for spinal placement. This novel approach is intended to address the mechanical and functional challenges unique to providing implantable stimulation to both the occipital and supraorbital nerves while delivering uninterrupted therapy 24 hours a day.

Key Highlights from the 12-Week Data:

Significant Reduction in Migraine Frequency: Participants experienced a substantial decrease in the number of headache and migraine days per month, alongside notable reductions in the severity of migraines.Improved Quality of Life: Participants reported marked enhancements in daily activities and overall well-being.High Safety Profile: The system demonstrated an excellent safety profile.

Dr. Falowski stated, “The RELIEV-CM study’s results are very promising. For the first time, we have a fully implantable neurostimulation system designed specifically for chronic migraine patients, placed in the head and above the flex points of the neck and spine. This customized approach reduced migraine frequency and significantly enhanced the quality of life for participants in the Pilot Study. This has the potential to be a transformative solution for millions suffering from chronic migraine disease.”

Physician Insights and Next Steps

Dr. Matthew Green, a Pain Medicine physician at Pain Med SA and the Director of CerCare Clinical Research in Adelaide, Australia, was among the first to implant the system. Reflecting on the Pilot Study, he said, “Our experience in this Australian Pilot Study has highlighted the positive health impacts of the innovative ShiraTronics Migraine Therapy System for chronic migraine suffers who have tried and failed standard treatment options. Excitingly, our participants have shown significant improvements in pain levels, migraine-days, and quality of life indicators. We look forward to continuing our involvement in the upcoming randomized controlled trial to further explore the benefits of this technology for patients worldwide.”

About ShiraTronics

ShiraTronics is a pioneering medical device company dedicated to developing state-of-the-art neurostimulation solutions aimed at improving the quality of life for patients with chronic migraine. “We are delighted to present these groundbreaking results to the global medical community,” said Rob Binney, President and CEO of ShiraTronics. “Our unwavering focus has always been on addressing the unmet needs of chronic migraine sufferers. The results of our Pilot Study validate the potential impact our therapy represents for the patients we serve, and who contend with the debilitating symptoms associated with chronic migraine. This data provides early indicators that our innovative platform has the potential to transform patient outcomes, restore functionality and improve quality of life. We are enthusiastic about accelerating our next phase of clinical research and continuing the relentless pursuit of our mission. Thank you to our Pilot Study investigators, advisors and, most importantly, our patients who participated in the RELIEV-CM Pilot Study.”

For more information about ShiraTronics and the RELIEV-CM study, please visit shiratronics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/shiratronics-unveils-data-on-their-neurostimulation-system-for-chronic-migraine-302195859.html

SOURCE ShiraTronics, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

AI-Powered Earbuds Transforming North American Smart Offices: Exclusive Insights from viaim CPO at CES 2025

Published

on

By

LAS VEGAS, Jan. 10, 2025 /PRNewswire/ — At CES 2025 in Las Vegas, Liu Da, Chief Product Officer (CPO) of viaim, an AI technology hardware company deeply rooted in the smart office sector, gave an exclusive interview, sharing valuable insights into viaim’s exploration of the field of AI-powered earbuds, its innovative product concepts, and how the technology addresses common workplace challenges in North America. Mr. Liu also delved into the market potential of AI-powered earbuds and viaim’s strategic blueprint for shaping the future of smart offices, especially in the North American market.

North American business professionals have widely embraced remote and hybrid work models. The rise of multilingual communication has fostered a highly digitalized consumer landscape with diverse user needs, particularly for smart office solutions. In response, viaim is dedicated to developing practical AI solutions that alleviate repetitive and tiring office tasks. By addressing the evolving demands of North American professionals with its AI-driven innovations, viaim is advancing its global mission to transform work efficiency and productivity.

Unique advantages of AI-powered smart earbuds

In the interview, Mr. Liu said earbuds, being close to the user’s senses, are seamlessly integrated into daily life and serve as an ideal platform for AI technology. Unlike traditional office hardware, AI-powered earbuds are portable and versatile, fitting various scenarios such as remote meetings, commuting, and entertainment. He highlighted that viaim’s AI-powered smart office solutions position the Company to bridge the gap between people and devices, transforming earbuds from simple audio tools into smart office partners. 

viaim’s technology and design challenges during the R&D  phase

Mr. Liu detailed the challenges the Company faced during the R&D phase, including integrating AI computing power, storage, and sensors into earbuds with limited space while maintaining portability and battery life. He also highlighted the difficulty of balancing human auditory sensitivity with machine signal processing to ensure a natural user experience. To tackle these challenges, viaim employed multi-terminal collaboration, integrating earbuds, apps, and cloud services to ensure seamless voice processing and secure data management tailored to the needs of North American professionals.

Market potential, insights, and positioning in North America

A report from Upwork, the world’s largest work marketplace, projects 36.2 million Americans will work remotely in 2025, marking an 87% increase from pre-pandemic levels. AI-powered earbuds, with capabilities including meeting recording and follow-up task management, cater to the digitalized and multilingual North American market. As remote and hybrid work rises, AI earbuds are becoming vital for workplace efficiency and language learning. viaim stands out with a competitive strategy focused on technological innovation and market segmentation, offering unique value beyond traditional earbud brands.

Future strategy and product vision

Mr. Liu believes technology’s true value lies in solving real-world problems. “When users actively engage with our AI solutions, it demonstrates their true value,” he stated. AI earbuds remain the Company’s core focus, empowering professionals to shift their attention from routine tasks to meaningful creative endeavors. Looking ahead, viaim plans to expand its product lineup to include smart glasses and office accessories, creating a comprehensive AI office ecosystem. The Company aims to rapidly iterate based on user feedback, expanding AI earbuds from niche to mass markets and advancing industry development.

Media Contact: 

Qian Wang
+86-15321782927
wangqian@vision-intelligence.tech

View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-powered-earbuds-transforming-north-american-smart-offices-exclusive-insights-from-viaim-cpo-at-ces-2025-302347888.html

SOURCE VIAIM

Continue Reading

Technology

Steller Unveils Group Trip Planning

Published

on

By

KIRKLAND, Wash., Jan. 10, 2025 /PRNewswire/ — Steller, a video-based, travel planning platform that allows travelers to discover, connect and book based on experiences shared by creators, introduced its most requested feature yet: group trip collaboration. The feature transforms how travelers plan group trips by consolidating everything—discovery, communication, organized planning, and booking—into one platform. 

Steller launches group trip planning, streamlining discovery, communication, and booking into one collaborative platform.

Traditional Trip planning involves multiple surfaces and when traveling with others, multiple communication channels. It is difficult to stay organized when communication is spread across text messages, social DMs, email, etc.  

Steller’s new collaboration feature eliminates communication chaos and streamlines trip planning by offering a central group hub for organizing every piece of the process. Travelers can invite others to join their Trip itinerary, keeping communication, discovery, and booking in one place. With Steller’s library of more than 30 million pieces of user generated travel content, groups can share videos of activities, dining spots, attractions, add notes, and co-create custom itineraries. Flexible itinerary views—list, map, and video—give everyone a complete picture of the plan to share and edit with their travel companions.

“Collaborative trip planning has been a top request from our community.  When we launched Trips by Steller   last January, we knew it would resonate, but the response has far exceeded expectations. In a short time, over 50,000 users have planned and booked trips by incorporating their favorite user-generated travel videos into personalized itineraries. For our destination clients,  Trips by Steller has seamlessly connected travel influencer marketing to planning and commerce. Steller clients see more than 18% of viewers who engage with their influencer campaigns planning trips to their destination—a result that sets a high bar in the travel industry. Adding collaboration to the mix amplifies that impact, inspiring more people to explore, engage and transact together!” said Pete Bryant, CEO of Steller. 

How It Works  

Whether it’s a getaway for two or a large group adventure, collaboration makes organizing travel plans easy with an all-in-one solution. 

Build Your Itinerary Together: Group members can contribute by adding things to do, activities, and notes.Stay Organized: Add notes and structure by day, activity, or group to eliminate confusion.Flexible Views: View your itinerary as a detailed list, on a map, or through video for a fully customizable planning experience.Real-Time Updates: Keep track of changes, additions, and edits made by group members.On-the-Go Access: Everyone can access the itinerary on their phone.

Steller continues to lead the charge in innovative travel planning, ensuring that its platform evolves based on user feedback. Collaborative trip planning is the latest step in its mission to evolve travel. 

About Steller 

Steller, headquartered in Kirkland, Wash., is the market leading travel planning platform that guides travelers from inspiration to planning and booking through authentic experiences of their favorite creators. Steller’s patent pending platform distributes millions of pieces of bespoke, worldwide video content that can be found and booked on the Steller app. Learn more at www.steller.co  and  stellerforbusiness.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/steller-unveils-group-trip-planning-302347630.html

SOURCE Steller

Continue Reading

Technology

RAAPID Raises Series A from M12, Microsoft’s Venture Fund to Scale Next-Generation Healthcare Risk Adjustment

Published

on

By

Company reports 300% revenue growth in 2024 and advances partnerships with nation’s leading health systems

LOUISVILLE, Ky., Jan. 10, 2025 /PRNewswire/ — RAAPID, the industry-leading healthcare AI company, announced today a significant Series A investment from M12, Microsoft’s venture fund. This strategic funding positions RAAPID to expand its groundbreaking Neuro-symbolic AI platform that is reshaping healthcare risk adjustment.

RAAPID’s explosive growth – marked by a 300% revenue increase in 2024 – demonstrates the market’s strong validation of its advanced technology platform. The company has quickly established itself as a trusted partner for major health plans and provider., At the core of RAAPID’s success is its pioneering VisionAI technology, which tackles one of healthcare’s most pressing challenges: making sense of unstructured medical data. While over 70% of medical records exist as unstructured data when shared outside EHRs, RAAPID’s AI engine transforms this complex information into actionable insights, enabling unprecedented accuracy in risk capture and care gap identification.

“Our vision extends beyond traditional risk adjustment,” states Chetan Parikh, Founder and CEO of RAAPID. “We’re creating a future where AI augments healthcare professionals’ capabilities, leading to better patient outcomes and more accurate appropriate reimbursements. This investment from M12 accelerates our mission to transform healthcare through advanced AI.”

RAAPID’s purpose-built Risk Adjustment platform has achieved remarkable results:

Slashing chart review time by 60-80%Surpassing industry standards with 95%+ coding accuracyGenerating additional appropriate and compliant revenue per memberImproving risk capture accuracy by 25%

The HITRUST-certified platform stands out for its unique Neuro-symbolic AI approach, combining neural networks with an extensive medical knowledge graph containing over 4 million clinical entities and 50 million relationships. This sophisticated technology enables both retrospective analysis and prospective risk adjustment, helping organizations identify and address care gaps to positively impact patient health.

“Healthcare organizations are increasingly seeking innovative solutions to manage risk and improve care delivery in value-based arrangements,” said Todd Graham, Managing Partner at M12. “RAAPID’s AI-driven risk adjustment platform aligns perfectly with our investment strategy. Through M12, we are committed to providing our portfolio companies with access to Microsoft’s resources and expertise to drive significant impact in the healthcare sector.

Led by a team with over 25 years of healthcare technology expertise, RAAPID has collaborated with experts from the top 4 tech giants in developing its clinical AI solutions. RAAPID continues to push the safe boundaries of what’s possible in healthcare AI. The company’s selection as an M12 portfolio company validates its position as a leader in healthcare technology innovation.

As value-based care becomes increasingly important, RAAPID’s AI-powered solutions are becoming essential tools for healthcare organizations striving to improve timeliness and quality of care all patients expect. With this new funding, RAAPID is poised to further advance its technology and expand its positive impact on patients, providers and payers.

About RAAPID
RAAPID develops AI-powered solutions for healthcare payers, providers, and supporting organizations. The company’s cloud-based risk adjustment platform uses neuro-symbolic AI to identify chronic conditions, determine HCC codes, calculate risk scores, and analyze population health trends. RAAPID serves organizations that participate in Medicare Advantage, ACA, Medicare ACO, and Medicaid programs.

For more information about RAAPID’s AI-powered risk adjustment solutions, visit www.raapidinc.com

CONTACT:
Mayur Vyas
(502) 699-3044
388583@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/raapid-raises-series-a-from-m12-microsofts-venture-fund-to-scale-next-generation-healthcare-risk-adjustment-302348014.html

SOURCE RAAPID

Continue Reading

Trending